APA Citatie

Del Re, M., Rofi, E., Restante, G., Crucitta, S., Arrigoni, E., Fogli, S., . . . Danesi, R. (2017). Implications of KRAS mutations in acquired resistance to treatment in NSCLC. Oncotarget.

Chicago Style citaat

Del Re, Marzia, Eleonora Rofi, Giuliana Restante, Stefania Crucitta, Elena Arrigoni, Stefano Fogli, Massimo Di Maio, Iacopo Petrini, en Romano Danesi. "Implications of KRAS Mutations in Acquired Resistance to Treatment in NSCLC." Oncotarget 2017.

MLA citatie

Del Re, Marzia, et al. "Implications of KRAS Mutations in Acquired Resistance to Treatment in NSCLC." Oncotarget 2017.